All Stories

  1. The impact of topical tranexamic acid on drain duration and seroma volume in axillary lymph node dissection for breast cancer: A randomized controlled trial

    Article • World Journal of Surgery, December 2024, Wiley

    Juan Garona

  2. Vasopressin Analog [V4Q5]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models

    Article • World Journal of Oncology, December 2023, Elmer Press, Inc.

    Juan Garona

  3. Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models

    Article • Chemico-Biological Interactions, October 2023, Elsevier

    Juan Garona

  4. Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy

    Article • Scientific Reports, September 2022, Springer Science + Business Media

    Juan Garona

  5. Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients

    Article • Viruses, October 2021, MDPI AG

    Dr Alejandro J Krolewiecki, Juan Garona

  6. Desmopressin in canine mammary carcinoma: Comments on the importance of the administration route

    Article • Veterinary and Comparative Oncology, August 2020, Wiley

    Juan Garona

  7. Drug Repurposing of β-blocker Propranolol in Osteosarcoma: Preclinical Antitumor Efficacy Alone or in Combination with Chemotherapy.

    Article • July 2020, Springer Science + Business Media

    Juan Garona

  8. Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial

    Article • Investigational New Drugs, March 2020, Springer Science + Business Media

    Juan Garona

  9. Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

    Article • Frontiers in Oncology, January 2020, Frontiers

    Juan Garona

  10. Development and therapeutic potential of vasopressin synthetic analog [V4Q5]dDAVP as a novel anticancer agent

    Article • January 2020, Elsevier

    Juan Garona

  11. Potential Use of Desmopressin During Hepatic Resection for Colorectal Liver Metastases*

    Article • Journal of Surgical Research, May 2019, Elsevier

    Juan Garona

  12. Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer

    Article • Cancer Research and Treatment, April 2019, Korean Cancer Association

    Juan Garona

  13. In Vitro and In Vivo Evaluation of desmopressin-loaded poly( D,L -lactic-co-glycolic acid) Nanoparticles for Its Potential Use in Cancer Treatment

    Article • Nanomedicine, November 2018, Taylor & Francis

    Juan Garona

  14. Search of vasopressin analogs with antiproliferative activity on small-cell lung cancer: drug design based on two different approaches

    Article • Future Medicinal Chemistry, April 2018, Future Science

    Juan Garona

  15. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer: Potential use of Perioperative Desmopressin to Reduce Allogenic Blood Transfusion Rates

    Article • Journal of Gastrointestinal Surgery, August 2017, Springer Science + Business Media

    Juan Garona

  16. CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models

    Article • Lung Cancer, May 2017, Elsevier

    Juan Garona

  17. Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells

    Article • Frontiers in Oncology, January 2017, Frontiers

    Juan Garona

  18. Urokinase Exerts Antimetastatic Effects by Dissociating Clusters of Circulating Tumor Cells--Letter

    Article • Cancer Research, August 2016, American Association for Cancer Research (AACR)

    Juan Garona

  19. Perioperative biology in primary breast cancer: selective targeting of vasopressin type 2 receptor using desmopressin as a novel therapeutic approach

    Article • Breast Cancer Research and Treatment, July 2016, Springer Science + Business Media

    Juan Garona

  20. Addition of vasopressin synthetic analogue [V4Q5]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models

    Article • Clinical & Experimental Metastasis, May 2016, Springer Science + Business Media

    Dr Daniel E Gomez, Juan Garona

  21. A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients

    Article • SpringerPlus, August 2015, Springer Science + Business Media

    Dr Daniel E Gomez, Juan Garona

  22. Abstract P6-11-07: Perioperative administration of desmopressin (dDAVP) in breast cancer patients: A phase II dose-escalation study

    Article • Cancer Research, April 2015, American Association for Cancer Research (AACR)

    Juan Garona

  23. The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models

    Article • International Journal of Oncology, April 2015, Spandidos Publications

    Dr Daniel E Gomez, Juan Garona

  24. Structure-activity relationship of 1-desamino-8-D-arginine vasopressin as an antiproliferative agent on human vasopressin V2 receptor-expressing cancer cells

    Article • Molecular Medicine Reports, April 2014, Spandidos Publications

    Dr Daniel E Gomez, Juan Garona

  25. Abstract P2-09-15: Effect of [4-valine 5-glutamine] desmopressin, a novel vasopressin analog, on human breast cancer cell growth in two-dimensional (2D) and three-dimensional (3D) cultures

    Article • Cancer Research, December 2013, American Association for Cancer Research (AACR)

    Juan Garona

  26. Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model

    Article • Breast Cancer Research and Treatment, October 2013, Springer Science + Business Media

    Dr Daniel E Gomez, Juan Garona

  27. The Functional Interaction between Acyl-CoA Synthetase 4, 5-Lipooxygenase and Cyclooxygenase-2 Controls Tumor Growth: A Novel Therapeutic Target

    Article • PLOS One, July 2012, PLOS

    Dr Daniel E Gomez, Juan Garona

  28. Abstract 2321: The novel vasopressin analog [4-valine 5-glutamine] desmopressin inhibits tumor growth and angiogenesis in V2 receptor-expressing breast cancer xenografts

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Juan Garona

  29. P3-01-07: A Murine Xenograft Model for the Study of Ciclooxygenase-2 Expression and Function in Human Breast Cancer.

    Article • Cancer Research, December 2011, American Association for Cancer Research (AACR)

    Juan Garona

  30. Antiproliferative effect of 1-deamino-8-D-arginine vasopressin analogs on human breast cancer cells

    Article • Future Medicinal Chemistry, December 2011, Future Science

    Dr Daniel E Gomez, Juan Garona

  31. Metastasis: Recent Discoveries and Novel Perioperative Treatment Strategies with Particular Interest in the Hemostatic Compound Desmopressin

    Article • Current Pharmaceutical Biotechnology, November 2011, Bentham Science Publishers

    Juan Garona

  32. Abstract 5473: Antiproliferative and antimetastasic activity of a novel vasopressin V2 receptor peptide agonist in a breast cancer model

    Article • Cancer Research, April 2010, American Association for Cancer Research (AACR)

    Juan Garona